Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $83M invested in Anthera Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 20 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
84% more call options, than puts
Call options by funds: $357K | Put options by funds: $194K
33% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 21
16% less funds holding
Funds holding: 86 → 72 (-14)
17% less capital invested
Capital invested by funds: $99.4M → $83M (-$16.4M)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$5.69M |
| 2 |
PA
Perceptive Advisors
New York
|
+$1.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$1.63M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$675K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$627K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.61M |
| 2 |
Renaissance Technologies
New York
|
-$1.25M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.08M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$861K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$650K |
ANTH Hedge Fund Activity: Q1 2016 in Review
72 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q1 2016, worth a combined $83M — down 17% from $99.4M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ANTH and 6 opened new positions — a net loss of 14 holders — while 21 trimmed existing stakes and 28 added.
The largest buyer was Sio Capital Management, adding an estimated $5.69M. The largest seller was Millennium Management, exiting entirely with an estimated $1.61M sold.
- 72 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q1 2016, down from 86 in Q4 2015.
- Funds reported $83M of Anthera Pharmaceuticals, Inc. stock for Q1 2016, down 17% quarter-over-quarter.
- 6 funds opened new Anthera Pharmaceuticals, Inc. positions in Q1 2016 and 20 closed out, a net change of -14 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q1 2016 was Sio Capital Management, an estimated $5.69M added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q1 2016 was Millennium Management, an estimated $1.61M sold.
Based on aggregated 13F filings for Q1 2016.